Carlene MacMillan, M.D., is a Harvard-trained board-certified adult, adolescent and child psychiatrist and the Chief Medical Officer at Osmind, a platform that enables clinicians to deliver breakthrough mental health treatments. She completed her undergraduate and medical degrees at Havard and then went on to complete residency and fellowship at Harvard's MGH/McLean Hospital. She is on the Board of Directors of the Clinical TMS Society and the Co-Chair of the CTMSS Insurance Committee. She is the Co-Chair of the American Academy of Child and Adolescent Psychiatry Consumer Issues Committee. Dr.MacMillan is on the board of the Ketamine Taskforce for Access to Safe Care and Insurance Coverage. She participates in real world evidence and post-marketing studies of transcranial magnetic stimulation and esketamine. She is extensively trained in Mentalization Based Treatment and applies it in individual, group therapy, family and team/systems settings.

As a psychiatric futurist, she speaks regularly at a wide range of conferences from the American Psychiatric Association to SXSW and to the media on a wide range of topics from psychedelic medicine to health tech innovations. Prior to Fermata, she was the inaugural Medical Director of the NYC Ellenhorn Private Assertive Community Treatment program and the founder of Brooklyn Minds, a groundbreaking high acuity outpatient mental health group practice which was acquired by Curated Mental Health in 2022. She is a mom to two amazing twins, one of whom also wants to be a “feelings doctor” who is “good at technology” when she grows up. She is licensed in NY, MA, NJ, CA, MS and TX.